Magellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use Disorder

Source :: Business Wire. January 16, 2018
Publication Year :: 2018
Abstract: Extends leadership in digital health innovation and launches pilot initiative around first ever FDA cleared prescription digital therapeutic from PEAR Therapeutics SCOTTSDALE, Ariz. -- Magellan Health, Inc. (NASDAQ: MGLN) has [...]

Subjects :: Evidence-based medicine -- Usage
Substance abuse -- Patient outcomes -- Care and treatment -- Usage
Behavioral medicine -- Usage
Patient compliance -- Usage
Cognitive-behavioral therapy -- Usage
Business
Business, international

Tools